<http://webisa.webdatacommons.org/54206488>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://www.w3.org/ns/prov#Entity> .
<http://webisa.webdatacommons.org/prov/255888038>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://webisa.webdatacommons.org/54206488> .
<http://webisa.webdatacommons.org/54206488>	<http://www.w3.org/ns/prov#wasQuotedFrom>	<pubmedcentralcanada.ca> .
<http://webisa.webdatacommons.org/54206488>	<http://www.w3.org/ns/prov#value>	"In conclusion, PLGA???PEG1500???PLGA with a lactide-to-glycolide ratio of 5:1 is an ideal system for the long-acting, controlled release of naltrexone hydrochloride and vitamin B12." .